Leandro MJ, Isenberg DA (2001) Rheumatic diseases and malignancy – is there an association? Scand J Rheumatol 30:185–188
CAS
PubMed
Google Scholar
Rosenthal AK, McLaughlin JK, Linet MS, Persson I (1993) Scleroderma and malignancy: an epidemiological study. Ann Rheum Dis 52:531–533
CAS
PubMed
Google Scholar
Bielefeld P (1991) Sclerodermie generalise et affection malignes: une revue de la litterature. Rev Med Interne12:350–353
Google Scholar
Doyle JA, Connolly SM, Hoagland HC (1985) Hematologic disease in scleroderma syndromes. Acta Dermatol Venereol (Stockh) 65:521–525
Google Scholar
Jaffe ES, Harris NL, Stein H, Vardiman JW (2001) Tumors of haematopoietic and lymphoid tisssues. World Health Organization Classification of Tumors. IARC Press, Lyon
Biasi D, Caramaschi P, Ambrosetti A et al. (2001) Mucosa-associated lymphoid tissue lymphoma of salivary glands occuring in patients affected by Sjögren’s syndrome: report of 6 cases. Acta Haematol 105:83–88
Article
CAS
PubMed
Google Scholar
Lens XM, Fernandez E, Panades MJ et al. (1992) Progressive systemic sclerosis and palmar hyperkeratosis as a paraneoplastic syndrome in non-Hodgkin’s lymphoma. Nephrol Dial Transplant 7:1166–1167
CAS
Google Scholar
Haviv YS, Ben-Yehuda A, Polliack A, Safadi R (1997) Lymphoma and systemic sclerosis—an uncommon association or possible coincidence of two disorders with fatal outcome. Eur J Haematol 59:194–196
CAS
PubMed
Google Scholar
Baldini L, Guffanti A, Ferrari A et al. (1994) Uncommon clinical presentation of lymphocytic lymphoma of intermediate differentiation in a patient with systemic sclerosis. Br J Haematol 86:657–658
CAS
PubMed
Google Scholar
Parma M, Sita G, Guffanti A, Bianchi F, Colombi M, Baldini L (1996) Multilobated B cell lymphoma (Pinkus variant) with isolated muscular localization in a patient with systemic sclerosis: a case report. Ann Haematol 73:43–45
Article
CAS
Google Scholar
Yamamoto T, Furuse Y, Nishioka K (1993) Progressive systemic sclerosis preceded by malignant lymphoma. J Dermatol 20:648–650
CAS
PubMed
Google Scholar
Roumm AD, Medsger TA (1985) Cancer and systemic sclerosis: an epidemiologic study. Arthritis Rheum 28:1336–1340
CAS
PubMed
Google Scholar
Tielsch JM, Linet MS, Szklo M (1987) Acquired disorders affecting the immune system and non-Hodgkin’s lymphoma. Prev Med 16:96–106
Article
CAS
PubMed
Google Scholar
Cartwright RA, McKinney PA, O’Brien C et al. (1988) Non-Hodgkin’s lymphoma: case control epidemiological study in Yorkshire. Leukemia Res 1988; 12:81–88
Google Scholar
Frizzera G (1994) Immunosuppresion, autoimmunity and lymphoproliferative disorders. Hum Pathol 25:627–629
CAS
PubMed
Google Scholar
Naschitz JE, Rosner I, Rozenbaum M, Zuckerman E, Yeshurun D (1999) Rheumatic syndromes: clues to occult neoplasia. Semin Arthritis Rheum 29:43–55
CAS
PubMed
Google Scholar
Wahl SM, McCartney FN, Mergenhagen SE (1989) Inflammatory and immunomodulatory roles of TGF. Immunol Today 10:258–261
CAS
PubMed
Google Scholar
Needleman BW, Wigley FN, Stair RW (1992) IL1, IL2, IL4, IL6, TNFα and INFγ levels in sera from patients with scleroderma. Arthritis Rheum 35:67–72
Google Scholar
Plantin P, Le Leannec N, Delmas A, Le Berre A, Leroy JP (1996) Lesion a type de morphees profondes premieres manifesation d’un lymphome lymphocytique. Ann Dermatol Venereol 123:468–470
CAS
PubMed
Google Scholar
Isaacson PG (1999) Mucosa-asoociated lymphoid tissue lymphoma. Semin Hematol 36:139–147
CAS
PubMed
Google Scholar
Harris NL (1999) Lymphoid proliferation of the salivary glands. Am J Clin Pathol 11 (suppl 1): S94–S104
Google Scholar